NO20035673D0 - Nye heteroarylderivater, deres fremstilling og anvendelse - Google Patents

Nye heteroarylderivater, deres fremstilling og anvendelse

Info

Publication number
NO20035673D0
NO20035673D0 NO20035673A NO20035673A NO20035673D0 NO 20035673 D0 NO20035673 D0 NO 20035673D0 NO 20035673 A NO20035673 A NO 20035673A NO 20035673 A NO20035673 A NO 20035673A NO 20035673 D0 NO20035673 D0 NO 20035673D0
Authority
NO
Norway
Prior art keywords
preparation
heteroaryl derivatives
disorders
disorder
new heteroaryl
Prior art date
Application number
NO20035673A
Other languages
English (en)
Other versions
NO20035673L (no
NO326514B1 (no
Inventor
Mario Rottlaender
Ejner Knud Moltzen
Ivan Mikkelsen
Thomas Ruhland
Kim Andersen
Christian Krog-Jensen
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of NO20035673L publication Critical patent/NO20035673L/no
Publication of NO20035673D0 publication Critical patent/NO20035673D0/no
Publication of NO326514B1 publication Critical patent/NO326514B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32Alcohol-abuse
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Addiction (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20035673A 2001-06-29 2003-12-18 Nye heteroarylderivater, deres fremstilling og anvendelse NO326514B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200101036 2001-06-29
PCT/DK2002/000435 WO2003002556A1 (en) 2001-06-29 2002-06-27 Novel heteroaryl derivatives, their preparation and use

Publications (3)

Publication Number Publication Date
NO20035673L NO20035673L (no) 2003-12-18
NO20035673D0 true NO20035673D0 (no) 2003-12-18
NO326514B1 NO326514B1 (no) 2008-12-22

Family

ID=8160598

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20035673A NO326514B1 (no) 2001-06-29 2003-12-18 Nye heteroarylderivater, deres fremstilling og anvendelse

Country Status (27)

Country Link
US (2) US20040248883A1 (no)
EP (1) EP1399438B1 (no)
JP (1) JP2004535449A (no)
KR (1) KR20040019026A (no)
CN (1) CN1310909C (no)
AT (1) ATE312094T1 (no)
AU (1) AU2002344949B2 (no)
BG (1) BG108531A (no)
BR (1) BR0210401A (no)
CA (1) CA2451228A1 (no)
CZ (1) CZ2004156A3 (no)
DE (1) DE60207857T2 (no)
DK (1) DK1399438T3 (no)
EA (1) EA006203B1 (no)
ES (1) ES2252471T3 (no)
HK (1) HK1068622A1 (no)
HU (1) HUP0400344A2 (no)
IL (1) IL158828A0 (no)
IS (1) IS2425B (no)
MX (1) MXPA03011769A (no)
NO (1) NO326514B1 (no)
NZ (1) NZ529460A (no)
PL (1) PL365249A1 (no)
SI (1) SI1399438T1 (no)
SK (1) SK652004A3 (no)
UA (1) UA75407C2 (no)
WO (1) WO2003002556A1 (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA74651C2 (en) * 2001-06-29 2006-01-16 Lundbeck & Co As H Indole derivatives, a pharmaceutical composition based thereon and use thereof
WO2003007956A1 (en) 2001-07-20 2003-01-30 Psychogenics, Inc. Treatment for attention-deficit hyperactivity disorder
US7262293B2 (en) * 2003-07-02 2007-08-28 Corus Pharma Aztreonam L-lysine and methods for the preparation thereof
US7160888B2 (en) 2003-08-22 2007-01-09 Warner Lambert Company Llc [1,8]naphthyridin-2-ones and related compounds for the treatment of schizophrenia
US7635696B2 (en) 2004-11-26 2009-12-22 Janssen Pharmaceutica N.V. Isoxazoline-indole derivatives with an improved antipsychotic and anxiolytic activity
US20120283434A1 (en) 2010-01-04 2012-11-08 Enantia, S.L. Process for the preparation of rivaroxaban and intermediates thereof
EP2559714B1 (en) 2010-04-12 2016-08-10 Lotte Chemical Corporation Method for preparing olefin-diene copolymer using transition metal compound including thiophene-condensed ring cyclopentadienyl ligand
US9062025B2 (en) 2010-04-12 2015-06-23 Lotte Chemical Corporation Supported catalyst for olefin polymerization and preparation method for polyolefin using the same
KR100986301B1 (ko) 2010-04-12 2010-10-07 아주대학교산학협력단 테트라하이드로퀴놀린 유도체로부터 유래한 티오펜-축합고리 싸이클로펜타디에닐 4족 금속 화합물 및 이를 이용한 올레핀 중합
JP5546678B2 (ja) 2010-04-12 2014-07-09 ロッテ ケミカル コーポレーション チオフェン−縮合環シクロペンタジエニルリガンドを含む遷移金属化合物を使用したポリプロピレンの製造方法
WO2011129590A2 (ko) 2010-04-12 2011-10-20 호남석유화학 주식회사 올레핀 중합용 촉매 조성물 및 이를 사용한 폴리올레핀의 제조방법

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2667068B1 (fr) * 1990-09-26 1994-09-09 Adir Nouvelles amines alkyl heterocycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
UA74651C2 (en) 2001-06-29 2006-01-16 Lundbeck & Co As H Indole derivatives, a pharmaceutical composition based thereon and use thereof

Also Published As

Publication number Publication date
NZ529460A (en) 2005-09-30
DK1399438T3 (da) 2006-04-18
CA2451228A1 (en) 2003-01-09
WO2003002556A1 (en) 2003-01-09
BG108531A (bg) 2004-08-31
EA006203B1 (ru) 2005-10-27
KR20040019026A (ko) 2004-03-04
HUP0400344A2 (hu) 2004-09-28
PL365249A1 (en) 2004-12-27
CZ2004156A3 (cs) 2004-05-12
AU2002344949B2 (en) 2007-05-24
US20040248883A1 (en) 2004-12-09
BR0210401A (pt) 2004-08-17
NO20035673L (no) 2003-12-18
ES2252471T3 (es) 2006-05-16
DE60207857D1 (de) 2006-01-12
IS2425B (is) 2008-10-15
CN1520410A (zh) 2004-08-11
SK652004A3 (en) 2004-09-08
EP1399438A1 (en) 2004-03-24
NO326514B1 (no) 2008-12-22
JP2004535449A (ja) 2004-11-25
DE60207857T2 (de) 2006-07-20
ATE312094T1 (de) 2005-12-15
US20080027071A1 (en) 2008-01-31
US7393845B2 (en) 2008-07-01
IL158828A0 (en) 2004-05-12
IS7021A (is) 2003-11-10
MXPA03011769A (es) 2004-04-02
UA75407C2 (en) 2006-04-17
SI1399438T1 (sl) 2006-04-30
HK1068622A1 (en) 2005-04-29
CN1310909C (zh) 2007-04-18
EP1399438B1 (en) 2005-12-07
EA200400102A1 (ru) 2004-04-29

Similar Documents

Publication Publication Date Title
HK1068622A1 (en) Novel heteroaryl derivatives, their preparation and use
RS20120158A3 (en) Phenyl-piperazine Derivatives As Serotonin Resorption Inhibitors
CY1108464T1 (el) Παραγωγα 4-(2-φαινυλοσουλφανυλο-φαινυλο)πιπεριδινης, ως αναστολεις επαναπροσληψεως σεροτονινης
NO20040680D0 (no) Nye dihydropterinonerfremgangsmate for fremstilling derav og deres anvendelse som legemiddel
HRP20080262T3 (en) 4-(2-phenyloxyphenyl)-piperidine or -1,2,3,6-tetrahydropyridine derivatives as serotonin reuptake inhibitors
ATE347555T1 (de) 6-aminomorphinanderivate, herstellungsverfahren dafür und deren verwendung
NO20055205L (no) 4-(2-fcnylsulfanyl-fenyl)-1,2,3,6-tydropyridinderivater som serotoniniopptaksinhibitorer
DE60201590D1 (de) Antidepressiv wirksame azaheterocyclymethyl-derivative von oxaheterocycyl-anellierten (1,4)-benzodioxanen
DE60213576D1 (de) ANTIDEPRESSIVE AZAHETEROCYCLYLMETHYL-DERIVATE VON 2,3-DIHYDRO-1,4-DIOXINOi2,3-föCHINOXALIN
DE60201447D1 (de) Antidepressive azaheterocyclylmethylderivate von 7,8-dihydro-1,6,9-trioxa-3-azacyclopenta(a)naphthalin
ATE304016T1 (de) Antidepressive (sssri) azaheterocyclylmethylderivate von 7,8-dihydro-3h- 6,9-dioxa-1,3-diazacyclopenta (a) naphthalin
MXPA03011766A (es) Novedosos derivados de indol.
UA81469C2 (en) 4-(2-phenyloxyphenyl)-piperidine or -1,2,3,6-tetrahydropyridine derivatives as serotonin reuptake inhibitors
SE0301796D0 (sv) New use II

Legal Events

Date Code Title Description
CREP Change of representative

Representative=s name: PLOUGMANN & VINGTOFT, POSTBOKS 1003 SENTRUM, 0104